| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $60,888,487 ) (Continued on the next page) |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AA027189 | Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol | 001 | 4 | NIH | 2/1/2022 | $346,640 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U24MH100925 | NNTC Data Coordinating Center | 000 | 10 | NIH | 2/9/2022 | $644,009 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U24MH100925 | NNTC Data Coordinating Center | 000 | 10 | NIH | 2/9/2022 | $131,318 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AI125588 | The role of arginine catabolic pathways in modulating staphylococcal fitness | 000 | 5 | NIH | 10/15/2021 | $376,250 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P20GM103427 | A cloud-based learning module to analyze ATAC-seq and single cell ATAC-seq data | 001 | 21 | NIH | 5/18/2022 | $3,627,570 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P20GM103427 | A cloud-based learning module to analyze ATAC-seq and single cell ATAC-seq data | 002 | 21 | NIH | 5/19/2022 | $147,748 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AI116723 | Optimization of Antischistosomal Chemotypes | 000 | 8 | NIH | 3/30/2022 | $625,607 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U0117261 | Partnership for Urban MCH Leadership Community | 01 | 12 | HRSA | 3/31/2022 | $133,488 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U0117261 | Partnership for Urban MCH Leadership Community | 01 | 12 | HRSA | 3/31/2022 | $222,480 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U0117261 | Partnership for Urban MCH Leadership Community | 01 | 12 | HRSA | 3/31/2022 | $33,372 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U0117261 | Partnership for Urban MCH Leadership Community | 00 | 12 | HRSA | 3/15/2022 | $106,512 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U0117261 | Partnership for Urban MCH Leadership Community | 00 | 12 | HRSA | 3/15/2022 | $177,520 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U0117261 | Partnership for Urban MCH Leadership Community | 00 | 12 | HRSA | 3/15/2022 | $26,628 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL126796 | Cardiac afferents and renal function in heart failure | 000 | 7 | NIH | 1/31/2022 | $514,498 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL126796 | Cardiac afferents and renal function in heart failure | 001 | 7 | NIH | 6/8/2022 | $57,167 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F31AA028743 | Hepatocyte-hepatic stellate cell axis in potentiation of alcohol and HIV-induced liver injury | 000 | 2 | NIH | 1/28/2022 | $45,134 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F31AA028743 | Hepatocyte-hepatic stellate cell axis in potentiation of alcohol and HIV-induced liver injury | 001 | 2 | NIH | 5/26/2022 | $716 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA215420 | Whole-of-Community Systems Intervention for Youth Population Physical Activity | 000 | 5 | NIH | 2/23/2022 | $481,714 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA215420 | Whole-of-Community Systems Intervention for Youth Population Physical Activity | 001 | 5 | NIH | 6/8/2022 | $42,824 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA228524 | Targeting CXCR2 axis in Pancreatic Cancer | 000 | 5 | NIH | 2/11/2022 | $362,302 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA228524 | Targeting CXCR2 axis in Pancreatic Cancer | 001 | 5 | NIH | 5/24/2022 | $32,206 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R25CA221777 | Ignite-Engage-Sustain: a comprehensive approach to motivate, involve, educate, and mentor Native American students and their communities in cancer prevention, treatment, and research | 000 | 5 | NIH | 2/10/2022 | $457,740 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA233037 | The novel role of microtubule regulators in the DNA damage response | 000 | 2 | NIH | 1/11/2022 | $301,529 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA233037 | The novel role of microtubule regulators in the DNA damage response | 001 | 2 | NIH | 3/11/2022 | $40,901 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA233037 | The novel role of microtubule regulators in the DNA damage response | 002 | 2 | NIH | 5/23/2022 | $26,803 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA233037 | The novel role of microtubule regulators in the DNA damage response | 003 | 2 | NIH | 5/26/2022 | $3,635 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA222649 | FGFR4 intracellular domain promotes tumor progression in cholangiocarcinoma | 000 | 5 | NIH | 12/14/2021 | $313,470 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA222649 | FGFR4 intracellular domain promotes tumor progression in cholangiocarcinoma | 001 | 5 | NIH | 5/26/2022 | $27,865 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F31HL156402 | Targeting metabolic remodeling and mitochondrial dysfunction in the diabetic heart | 000 | 2 | NIH | 1/24/2022 | $34,304 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F31HL156402 | Targeting metabolic remodeling and mitochondrial dysfunction in the diabetic heart | 001 | 2 | NIH | 6/7/2022 | $716 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AA026723 | Impaired phospholipid methylation results in decreased lipid droplet lipolysis: Role in hepatic steatosis | 000 | 5 | NIH | 3/30/2022 | $314,573 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01NS109381 | The Role of Astrocytes in the Fragile X Pathogenesis | 000 | 4 | NIH | 12/20/2021 | $411,539 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P01CA217798 | Pancreatic Cancer Metastasis | 000 | 5 | NIH | 5/25/2022 | $1,611,403 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01NS107369 | Immune mechanisms that promote S. aureus persistence during craniotomy-associated biofilm infection | 000 | 5 | NIH | 3/29/2022 | $412,212 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | K23AI134307 | Clinical Pharmacology of Efavirenz Combined with High Dose Rifapentine | 000 | 5 | NIH | 3/29/2022 | $162,603 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P20GM121316 | Nebraska Center for Molecular Target Discovery and Development | 001 | 5 | NIH | 3/7/2022 | $2,043,205 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P20GM121316 | Nebraska Center for Molecular Target Discovery and Development | 002 | 5 | NIH | 6/17/2022 | $227,025 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AI139176 | Coxiella manipulation of cholesterol in the intracellular niche | 001 | 6 | NIH | 4/21/2022 | $422,874 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01NS034239 | Neuroprotective Immunity and HIV Dementia | 000 | 27 | NIH | 3/18/2022 | $563,091 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AA027189 | Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol | 001 | 4 | NIH | 2/1/2022 | $115,545 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AI132406 | Regulatory Role of Tandem Tryptophan Codons in Chlamydial Persistence | 000 | 4 | NIH | 1/20/2022 | $592,167 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA239688 | Mechanisms of Genome Instability in Tumors with DNA Polymerase Epsilon Mutations | 001 | 3 | NIH | 1/14/2022 | $186,660 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA239688 | Mechanisms of Genome Instability in Tumors with DNA Polymerase Epsilon Mutations | 000 | 3 | NIH | 12/24/2021 | $313,959 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA239688 | Mechanisms of Genome Instability in Tumors with DNA Polymerase Epsilon Mutations | 002 | 3 | NIH | 5/19/2022 | $27,908 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL137319 | MMP-12 as an Endogenous Post-MI Resolution Promoting Factor | 001 | 4 | NIH | 6/9/2022 | $38,125 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL137319 | MMP-12 as an Endogenous Post-MI Resolution Promoting Factor | 000 | 4 | NIH | 1/13/2022 | $343,125 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DK120533 | Development of siRNA conjugates for combination treatment of acute kidney injury | 000 | 5 | NIH | 6/21/2022 | $411,750 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01EB027662 | A ratiometric fluorescent sensor array for bacterial pathogen investigation | 000 | 4 | NIH | 5/27/2022 | $343,125 |
| | 2022 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01EY030507 | Influence of ocular hypertension on neurons and synapses in the visual thalamus | 000 | 4 | NIH | 6/6/2022 | $369,813 |
|
